Daily Technical Analysis Weekly Analysis Monthly Analysis Renko chart MACD chart Bollinger Bands chart Stochastics charts Force Index charts

(GLAXO) Glaxosmithkline Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Glaxosmithkline Pharmaceuticals | (GLAXO) share price targets

Complete technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO) by charts plus indicators, forecast predictions and share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Glaxosmithkline Pharmaceuticals trades in NSE in Pharmaceuticals sector.

Showing technical analysis as on 2025-01-21 View latest technical analysis

10 day averaged volume of Glaxosmithkline Pharmaceuticals is 81289

Date	Daily Closing Price	Open	High	Low	Volume
21 Tue Jan 2025	2146.00	2128.30	2202.00	2110.10	2.059 times
20 Mon Jan 2025	2135.50	2065.00	2149.50	2048.00	1.376 times
17 Fri Jan 2025	2063.30	2050.00	2069.70	2013.85	1.267 times
16 Thu Jan 2025	2053.05	2052.00	2069.20	2013.30	0.742 times
15 Wed Jan 2025	2042.50	2086.00	2116.40	1987.00	1.397 times
14 Tue Jan 2025	2072.05	2100.05	2118.00	2051.00	0.815 times
13 Mon Jan 2025	2093.35	2143.00	2165.80	2078.95	1.021 times
10 Fri Jan 2025	2190.40	2208.35	2213.90	2141.35	1.097 times
09 Thu Jan 2025	2208.35	2201.00	2231.00	2201.00	0.421 times
08 Wed Jan 2025	2208.00	2231.10	2241.55	2185.10	0.674 times

Stock of Glaxosmithkline Pharmaceuticals (GLAXO) has showed a significant upmove. This could be a good time to enter in this stock!

My analysis of stock is bearish for shortterm, and stock might move down till 2104.2 or till 2015.6. Use a stoploss of 2177.97 and if the stock hits stoploss, then it can shoot up till 2251.77

Share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Target Type	Value
Downside Target	1987.00
Downside Target	2048.00
Downside Target	2141.35
Upside Target	2292.65
Upside Target	2307.00
Upside Target	2457.75
Upside Target	2500.00
Upside Target	2676.25
Upside Target	2742.95
Upside Target	2889.90
Upside Target	2922.80

Intraday share price targets for Glaxosmithkline Pharmaceuticals (GLAXO)

Target Type	Value
Downside Intraday Target	2062
Downside Intraday Target	1978
Upside Intraday Target	2216
Upside Intraday Target	2286
Downside Intraday Target	2132

Weekly technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Date	Weekly Closing Price	Open	High	Low	Volume
21 Tue Jan 2025	2146.00	2065.00	2202.00	2048.00	0.655 times
17 Fri Jan 2025	2063.30	2143.00	2165.80	1987.00	1.227 times
10 Fri Jan 2025	2190.40	2236.00	2248.95	2141.35	0.751 times
03 Fri Jan 2025	2241.05	2274.45	2280.15	2158.40	3.053 times
27 Fri Dec 2024	2274.45	2275.95	2292.65	2213.40	0.362 times

Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.

Monthly technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Date	Monthly Closing Price	Open	High	Low	Volume
21 Tue Jan 2025	2146.00	2235.00	2272.00	1987.00	0.668 times
31 Tue Dec 2024	2251.85	2436.00	2457.75	2158.40	0.973 times
29 Fri Nov 2024	2444.40	2729.00	2742.95	2307.00	0.867 times
31 Thu Oct 2024	2712.25	2751.00	2889.90	2500.00	1.386 times

Scroll below to view daily charts

Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.

Indicators analysis of Glaxosmithkline Pharmaceuticals (GLAXO)

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

Price action analysis of Glaxosmithkline Pharmaceuticals ( (GLAXO) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.

ADX buy sell signal for Glaxosmithkline Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.

MACD generated a BUY signal for Glaxosmithkline Pharmaceuticals in short term but the buy signal is initial and weak.

MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.

Glaxosmithkline Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!

Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up

CCI has generated a buy signal for Glaxosmithkline Pharmaceuticals in short term and BUY signal is strong.

RSI is generating a SELL signal in short term and selling is picking up momentum.

MRSI is in negative zone. This is the SELL zone

Stock of Glaxosmithkline Pharmaceuticals is picking up buying momentum according to indicator.

Volume based indicators are showing selling momentum.

Volume Weighted Averaged Price (VWAP) for short term is 2115.64 and Glaxosmithkline Pharmaceuticals (GLAXO) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down

People seem to be coming out and selling the Glaxosmithkline Pharmaceuticals (GLAXO) stock. Volume based technical analysis of Glaxosmithkline Pharmaceuticals (GLAXO) stock is negative.

Glaxosmithkline Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.

Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.